{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T17:06:02Z","timestamp":1771952762512,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.yebeh.2026.110936","type":"journal-article","created":{"date-parts":[[2026,2,16]],"date-time":"2026-02-16T16:59:39Z","timestamp":1771261179000},"page":"110936","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Influence of epilepsy syndrome on cancer comorbidity"],"prefix":"10.1016","volume":"177","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1514-7358","authenticated-orcid":false,"given":"L\u00e9nia","family":"Silva","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6616-0806","authenticated-orcid":false,"given":"Joana","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2336-4208","authenticated-orcid":false,"given":"Vanessa","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8296-883X","authenticated-orcid":false,"given":"Raquel","family":"Sam\u00f5es","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9803-9584","authenticated-orcid":false,"given":"Carolina","family":"Lemos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00e1rbara","family":"Leal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jo\u00e3o","family":"Chaves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.yebeh.2026.110936_b0005","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S1474-4422(15)00225-2","article-title":"Comorbidities of epilepsy: current concepts and future perspectives","volume":"15","author":"Keezer","year":"2016","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110936_b0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1002\/epd2.20048","article-title":"Different relationships between epilepsy syndromes and autoimmune diseases","volume":"25","author":"Chaves","year":"2023","journal-title":"Epileptic Disord"},{"key":"10.1016\/j.yebeh.2026.110936_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2019.106886","article-title":"Social impairment and stigma in genetic generalized epilepsies","volume":"104","author":"Gabriel","year":"2020","journal-title":"Epilepsy Behav"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110936_b0020","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/brain\/awh363","article-title":"Cancer risk in people with epilepsy: the role of antiepileptic drugs","volume":"128","author":"Singh","year":"2004","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.yebeh.2026.110936_b0025","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1600-0404.2011.01607.x","article-title":"Cancer risk in people with epilepsy using valproate-sodium","volume":"125","author":"Singh","year":"2012","journal-title":"Acta Neurol Scand"},{"issue":"4","key":"10.1016\/j.yebeh.2026.110936_b0030","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0147-6513(78)90014-3","article-title":"Is phenobarbital carcinogenic? a follow-up of 8078 epileptics","volume":"1","author":"Clemmesen","year":"1978","journal-title":"Ecotoxicol Environ Saf"},{"issue":"10","key":"10.1016\/j.yebeh.2026.110936_b0035","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1093\/jnci\/81.10.803","article-title":"Cancer among epileptic patients exposed to anticonvulsant drugs","volume":"81","author":"Olsen","year":"1989","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110936_b0040","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1136\/jnnp.2005.083931","article-title":"Epilepsy as a risk factor for cancer","volume":"77","author":"Adelow","year":"2006","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.yebeh.2026.110936_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2023.120584","article-title":"Epilepsy and brain tumors: two sides of the same coin","volume":"446","author":"Aronica","year":"2023","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.yebeh.2026.110936_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2020.106396","article-title":"Immunogenetic protective factors in genetic generalized epilepsy","volume":"166","author":"Chaves","year":"2020","journal-title":"Epilepsy Res"},{"issue":"2","key":"10.1016\/j.yebeh.2026.110936_b0055","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1093\/brain\/awac293","article-title":"\u2018Hippocampal innate inflammatory gliosis only\u2019 in pharmacoresistant temporal lobe epilepsy","volume":"146","author":"Grote","year":"2023","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.yebeh.2026.110936_b0060","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2010.06.002","article-title":"Why mesial temporal lobe epilepsy with hippocampal sclerosis is progressive: uncontrolled inflammation drives disease progression?","volume":"296","author":"Yang","year":"2010","journal-title":"J Neurol Sci"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110936_b0065","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/epi.17236","article-title":"ILAE definition of the idiopathic generalized epilepsy syndromes: position statement by the ILAE Task Force on Nosology and Definitions","volume":"63","author":"Hirsch","year":"2022","journal-title":"Epilepsia"},{"issue":"7","key":"10.1016\/j.yebeh.2026.110936_b0070","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1111\/epi.12220","article-title":"International consensus classification of hippocampal sclerosis in temporal lobe epilepsy: a Task Force report from the ILAE Commission on Diagnostic Methods","volume":"54","author":"Bl\u00fcmcke","year":"2013","journal-title":"Epilepsia"},{"issue":"3 Suppl 1","key":"10.1016\/j.yebeh.2026.110936_b0075","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/j.amepre.2013.10.029","article-title":"Age and cancer risk","volume":"46","author":"White","year":"2014","journal-title":"Am J Prev Med"},{"issue":"8","key":"10.1016\/j.yebeh.2026.110936_b0080","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.31557\/APJCP.2025.26.8.2709","article-title":"The functional interplay among GAD2, GABRG2, and CACNA1G genes in cancers","volume":"26","author":"Indrasari","year":"2025","journal-title":"Asian Pac J Cancer Prev"},{"issue":"7","key":"10.1016\/j.yebeh.2026.110936_b0085","article-title":"Meta-analysis of public microarray datasets reveals voltage-gated calcium gene signatures in clinical cancer patients","volume":"10","author":"Wang","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.yebeh.2026.110936_b0090","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.ajhg.2019.05.020","article-title":"Ultra-rare genetic variation in the epilepsies: a whole-exome sequencing study of 17,606 individuals","volume":"105","author":"Feng","year":"2019","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.yebeh.2026.110936_b0095","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e24455","article-title":"A pan-cancer analysis of the prognosis and immune infiltration of eEF1A2 and its potential function in thyroid carcinoma","volume":"10","author":"Ma","year":"2024","journal-title":"Heliyon"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110936_b0100","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1001\/jamaneurol.2023.0473","article-title":"Contribution of somatic Ras\/Raf\/MAPK variants in the hippocampus in drug-resistant mesial temporal lobe epilepsy","volume":"80","author":"Khoshkhoo","year":"2023","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110936_b0105","first-page":"1007","article-title":"ERK\/MAPK signalling pathway and tumorigenesis: a review","volume":"19","author":"Guo","year":"2020","journal-title":"Exp Ther Med"},{"issue":"6","key":"10.1016\/j.yebeh.2026.110936_b0110","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1001\/jamaneurol.2023.0465","article-title":"Oncogenic pathways provide clues to the etiology of human mesial temporal lobe epilepsy","volume":"80","author":"Goldman","year":"2023","journal-title":"JAMA Neurol"},{"issue":"9","key":"10.1016\/j.yebeh.2026.110936_b0115","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1080\/00207454.2016.1264396","article-title":"Age of onset of mesial temporal lobe epilepsy with hippocampal sclerosis: the effect of apolipoprotein E and febrile seizures","volume":"127","author":"Leal","year":"2017","journal-title":"Int J Neurosci"},{"key":"10.1016\/j.yebeh.2026.110936_b0120","article-title":"NLRP3 and NLRP1 inflammasomes are upregulated in mesial temporal lobe epilepsy and may contribute to IL-1\u03b2 overexpression in sclerotic hippocampi","volume":"1752","author":"de Brito Toscano","year":"2021","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2026.110936_b0125","doi-asserted-by":"crossref","unstructured":"Lin C, Zhang J. Inflammasomes in inflammation-induced cancer. Front Immunol. 2017;8:271.","DOI":"10.3389\/fimmu.2017.00271"},{"issue":"12","key":"10.1016\/j.yebeh.2026.110936_b0130","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.3324\/haematol.2014.106401","article-title":"Critical role of SHP2 (PTPN11) signaling in germinal center-derived lymphoma","volume":"99","author":"Jiang","year":"2014","journal-title":"Haematologica"},{"issue":"10","key":"10.1016\/j.yebeh.2026.110936_b0135","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.2174\/1570159X21666221214170234","article-title":"The JAK\u2013STAT signaling pathway in epilepsy","volume":"21","author":"Sun","year":"2023","journal-title":"Curr Neuropharmacol"},{"issue":"5","key":"10.1016\/j.yebeh.2026.110936_b0140","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00415-009-5021-x","article-title":"Interleukin-6 levels are increased in temporal lobe epilepsy but not in extratemporal lobe epilepsy","volume":"256","author":"Liimatainen","year":"2009","journal-title":"J Neurol"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110936_b0145","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12974-018-1139-z","article-title":"LncRNA H19 contributes to hippocampal glial activation via JAK\/STAT signaling in a rat model of temporal lobe epilepsy","volume":"15","author":"Han","year":"2018","journal-title":"J Neuroinflammation"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110936_b0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/ana.26644","article-title":"Selective neuronal knockout of STAT3 inhibits epilepsy progression and restores dysregulated gene networks","volume":"94","author":"Tipton","year":"2023","journal-title":"Ann Neurol"},{"issue":"3","key":"10.1016\/j.yebeh.2026.110936_b0155","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.3892\/mmr.2017.6865","article-title":"Matrine increases the inhibitory effects of afatinib via IL-6\/JAK1\/STAT3 signaling","volume":"16","author":"Chen","year":"2017","journal-title":"Mol Med Rep"},{"issue":"3","key":"10.1016\/j.yebeh.2026.110936_b0160","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/intimm\/dxaa078","article-title":"IL-6 in inflammation, autoimmunity and cancer","volume":"33","author":"Hirano","year":"2021","journal-title":"Int Immunol"},{"key":"10.1016\/j.yebeh.2026.110936_b0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2022.106858","article-title":"Cytokine\u2013chemokine profiles in the hippocampus of patients with mesial temporal lobe epilepsy and hippocampal sclerosis","volume":"180","author":"Aulick\u00e1","year":"2022","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2026.110936_b0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/435342","article-title":"The role of mTOR inhibitors in B-cell lymphomas","volume":"2012","author":"Argyriou","year":"2012","journal-title":"Adv Hematol"},{"key":"10.1016\/j.yebeh.2026.110936_b0175","series-title":"Jasper\u2019s Basic Mechanisms of the Epilepsies","first-page":"45","article-title":"mTOR in acquired and genetic models of epilepsy","author":"Wong","year":"2024"},{"issue":"Suppl 1","key":"10.1016\/j.yebeh.2026.110936_b0180","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1528-1167.2012.03478.x","article-title":"The mTOR pathway is activated in glial cells in mesial temporal sclerosis","volume":"53","author":"Sosunov","year":"2012","journal-title":"Epilepsia"},{"issue":"2 Suppl","key":"10.1016\/j.yebeh.2026.110936_b0185","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5698\/1535-7511-14.s2.3","article-title":"Epilepsy and inflammation in the brain: overview and pathophysiology","volume":"14","author":"Vezzani","year":"2014","journal-title":"Epilepsy Curr"},{"issue":"4","key":"10.1016\/j.yebeh.2026.110936_b0190","doi-asserted-by":"crossref","first-page":"350","DOI":"10.5152\/npa.2016.12678","article-title":"Cytokine polymorphism and HLA genotyping in temporal lobe epilepsy with hippocampal sclerosis","volume":"54","author":"Altintas","year":"2017","journal-title":"Noro Psikiyatr Ars"},{"issue":"1","key":"10.1016\/j.yebeh.2026.110936_b0195","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1111\/epi.18146","article-title":"High-dose folic acid use and cancer risk in women who have given birth: a register-based cohort study","volume":"66","author":"Vegrim","year":"2025","journal-title":"Epilepsia"},{"issue":"8","key":"10.1016\/j.yebeh.2026.110936_b0200","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1111\/epi.16610","article-title":"A pragmatic algorithm to select antiseizure medications in patients with epilepsy","volume":"61","author":"Asadi-Pooya","year":"2020","journal-title":"Epilepsia"},{"issue":"2","key":"10.1016\/j.yebeh.2026.110936_b0205","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/j.jaad.2019.05.055","article-title":"Use of antiepileptic drugs and risk of skin cancer: a nationwide case\u2013control study","volume":"82","author":"Kristensen","year":"2020","journal-title":"J Am Acad Dermatol"},{"issue":"Pt 1","key":"10.1016\/j.yebeh.2026.110936_b0210","first-page":"7","article-title":"Cancer risk in people with epilepsy: the role of antiepileptic drugs","volume":"128","author":"Singh","year":"2005","journal-title":"Brain"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000570?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505026000570?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:28:26Z","timestamp":1771950506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505026000570"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":42,"alternative-id":["S1525505026000570"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110936","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of epilepsy syndrome on cancer comorbidity","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2026.110936","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110936"}}